Express Pharma - Page 272 of 2194 - Express Pharma

Panel Discussion: India as an injectable hub: Growing CDMO strength and global partnerships

Mr Sridhar Balasubramanian, Head Quality – Sterile / Parenteral, Dr Reddy’s Laboratories

Panel Discussion: Beyond generics: Moving into complex injectables, oncology and biosimilars

Special Address: Anil Matai, Director General, OPPI

Datopotamab deruxtecan demonstrates positive results in TROPION-Lung01 Phase III trial

Special Address: Dr Rajiv Chhibber, Jt. Coordinator, Govt. & Public Affairs, AIMeD

Panel Discussion on ‘Decoding the dynamics of medical devices supply chain’

Dhruv Thakkar, VP-Business Development, India, DHL Supply Chain India

Harish Chandra Joshi, Global Head – Strategy and Portfolio, Propix Technologies

Panel Discussion on ‘From fragile to agile: Building resilience in pharma supply chain the face of disruptions’

Panel Discussion: Supply chains of tomorrow: Secure, smart, sustainable

Presentation of Citations: ‘Champion of Change’

Drug shortage in the US to prove beneficial for Indian pharma companies